NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School. We are using synthetic biology approaches to develop a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.